Kentaro Kubo

1.2k citations
65 papers · 898 indexed · h-index 17
Topics
Esophageal Cancer Research and Treatment (23 papers)Gastric Cancer Management and Outcomes (17 papers)Esophageal and GI Pathology (17 papers)

In The Last Decade

Kentaro Kubo

58 papers receiving 853 citations

Peers

Kentaro Kubo
Comparison fields: 5 of 82
  • Rehabilitation 292
  • Surgery 263
  • Molecular Biology 179
  • Biomaterials 170
  • Biomedical Engineering 119
Replace Kenji Hayashida with:
Kenji Hayashida Japan
Takamitsu Ishizuka Japan
Shaobin Huang China
Marcus Wong Singapore
James N. Fisher Italy
Jiecong Wang China
Adrian Băican Romania
Yi‐Juan Tan China
M. Ann Kuhn United States
Masamitsu Kuwahara Japan
Kentaro Kubo relative to Kenji Hayashida Japan Kenji Hayashida's profile →
Citations per field
00.5×1.5×2.1×
Kenji Hayashida · 1×
Citations per year

Countries citing papers authored by Kentaro Kubo

Since Specialization
Citations

This map shows the geographic impact of Kentaro Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Kubo more than expected).

Fields of papers citing papers by Kentaro Kubo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Kubo. The network helps show where Kentaro Kubo may publish in the future.

Co-authorship network of co-authors of Kentaro Kubo

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Kubo. A scholar is included among the top collaborators of Kentaro Kubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Kubo. Kentaro Kubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 5
6 0
7 5
8 12
9 2
10 3
11 3
12 7
13 1
14 7
15 7
16 1
17 16
18 55
19 41
20 28

About Kentaro Kubo

Kentaro Kubo is a scholar working on Rehabilitation, Pulmonary and Respiratory Medicine and Surgery, having authored 65 papers that have together received 898 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (23 papers), Gastric Cancer Management and Outcomes (17 papers) and Esophageal and GI Pathology (17 papers). The work is most often cited by research in Rehabilitation (292 citations), Urology (86 citations) and Biomaterials (170 citations). Kentaro Kubo has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoshimitsu Kuroyanagi, Toshio Inui, Yoshihiro Uto, Yoshitaka Maki, Hideaki Nagaya, Takahito Nishikata, Hitoshi Hori, Norihiro Sakamoto, Shizuko Kagawa and Tsuyoshi Nishi. Their work appears in journals such as Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Journal of Experimental Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026